Corebridge Financial, Inc.

DB:AS5 Stock Report

Market Cap: €17.3b

Corebridge Financial Valuation

Is AS5 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AS5 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AS5 (€30) is trading below our estimate of fair value (€63.37)

Significantly Below Fair Value: AS5 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AS5?

Key metric: As AS5 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AS5. This is calculated by dividing AS5's market cap by their current revenue.
What is AS5's PS Ratio?
PS Ratio1.1x
SalesUS$15.98b
Market CapUS$18.06b

Price to Sales Ratio vs Peers

How does AS5's PS Ratio compare to its peers?

The above table shows the PS ratio for AS5 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.5x
HYQ Hypoport
3.4x11.5%€1.4b
VVV3 Ökoworld
3.4x4.6%€209.0m
DBK Deutsche Bank
1.1x4.2%€30.2b
DWS DWS Group GmbH KGaA
2x-4.3%€7.9b
AS5 Corebridge Financial
1.1x12.2%€18.1b

Price-To-Sales vs Peers: AS5 is good value based on its Price-To-Sales Ratio (1.1x) compared to the peer average (2.5x).

Price to Sales Ratio vs Industry

How does AS5's PS Ratio compare vs other companies in the DE Diversified Financial Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
EBEN aifinyo
0.3xn/aUS$15.51m
EBEN aifinyo
0.2xn/aUS$13.83m
CSQ creditshelf
0.005xn/aUS$29.07k
No more companies available in this PS range
AS5 1.1xIndustry Avg. 1.9xNo. of Companies3PS01.22.43.64.86+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: AS5 is good value based on its Price-To-Sales Ratio (1.1x) compared to the European Diversified Financial industry average (1.9x).

Price to Sales Ratio vs Fair Ratio

What is AS5's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AS5 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.1x
Fair PS Ratio2.9x

Price-To-Sales vs Fair Ratio: AS5 is good value based on its Price-To-Sales Ratio (1.1x) compared to the estimated Fair Price-To-Sales Ratio (2.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AS5 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€30.00
€34.64
+15.5%
6.9%€40.07€31.48n/a13
Nov ’25€29.00
€31.66
+9.2%
5.5%€36.07€28.67n/a13
Oct ’25€26.00
€30.54
+17.5%
7.1%€35.19€26.17n/a13
Sep ’25€26.00
€30.45
+17.1%
6.5%€33.38€26.16n/a12
Aug ’25€27.20
€31.12
+14.4%
11.8%€37.07€22.24n/a12
Jul ’25€27.00
€30.68
+13.6%
15.0%€37.38€22.43n/a12
Jun ’25€26.80
€29.26
+9.2%
17.2%€36.87€19.36n/a12
May ’25€25.00
€29.17
+16.7%
17.4%€37.64€19.76n/a12
Apr ’25€26.00
€26.37
+1.4%
14.6%€32.38€19.43n/a12
Mar ’25€23.20
€26.37
+13.7%
14.6%€32.38€19.43n/a12
Feb ’25€22.20
€25.17
+13.4%
11.8%€30.36€19.32n/a14
Jan ’25€19.60
€23.56
+20.2%
8.0%€26.94€19.51n/a14
Dec ’24€18.80
€23.63
+25.7%
8.0%€27.10€19.62n/a14
Nov ’24€18.80
€23.49
+24.9%
9.3%€27.32€18.84€29.0014
Oct ’24€18.60
€23.56
+26.7%
10.4%€29.13€18.79€26.0013
Sep ’24€16.30
€22.93
+40.7%
10.8%€28.43€18.34€26.0013
Aug ’24€16.90
€21.72
+28.5%
11.4%€26.68€16.90€27.2012
Jul ’24€16.10
€22.29
+38.5%
12.9%€29.44€16.56€27.0013
Jun ’24€15.50
€23.00
+48.4%
13.4%€29.74€16.73€26.8012
May ’24€15.00
€22.15
+47.7%
15.0%€28.98€16.30€25.0013
Apr ’24€14.50
€24.18
+66.8%
9.4%€29.85€20.52€26.0013
Mar ’24€18.90
€25.03
+32.4%
9.4%€30.18€21.69€23.2013
Feb ’24€19.90
€24.21
+21.7%
9.2%€30.46€21.23€22.2013
Jan ’24€18.80
€25.01
+33.0%
8.9%€32.03€22.32€19.6013
Dec ’23€21.20
€25.01
+18.0%
8.9%€32.03€22.32€18.8013
Nov ’23€22.60
€25.51
+12.9%
7.1%€30.71€23.54€18.8013

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Yeahka

HK$4.2b

An investment holding company, provides payment and business services to merchants and consumers in the People’s Republic of China.

4YE

HK$1.19

7D

-2.5%

1Y

-30.0%

ORIX

JP¥3.8t

Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.

OIX

JP¥20.20

7D

-1.0%

1Y

22.4%

Merchants Bancorp

US$1.9b

Operates as the diversified bank holding company in the United States.

3KD

US$39.00

7D

2.6%

1Y

28.3%